NYSE:TFX - Teleflex Stock Price, Forecast & News

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Teleflex announced a dividend on Thursday, October 31st. Shareholders of record on Friday, November 15th will be given a dividend of $0.34 per share on Monday, December 16th. The ex-dividend date of this dividend is Thursday, November 14th. View Teleflex's Dividend History.

Teleflex Incorporated (NYSE:TFX) released its quarterly earnings data on Thursday, October, 31st. The medical technology company reported $2.97 EPS for the quarter, topping the Zacks' consensus estimate of $2.75 by $0.22. The medical technology company had revenue of $648.32 million for the quarter, compared to the consensus estimate of $643.20 million. Teleflex had a return on equity of 18.81% and a net margin of 17.36%. The company's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company posted $2.52 EPS. View Teleflex's Earnings History.

Teleflex is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Teleflex.

9 brokers have issued twelve-month price targets for Teleflex's stock. Their forecasts range from $365.00 to $430.00. On average, they expect Teleflex's stock price to reach $405.33 in the next twelve months. This suggests a possible upside of 6.7% from the stock's current price. View Analyst Price Targets for Teleflex.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Teleflex.

Press coverage about TFX stock has trended extremely negative on Sunday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Teleflex earned a media sentiment score of -4.5 on InfoTrie's scale. They also gave headlines about the medical technology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Teleflex.

Teleflex saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 755,900 shares, an increase of 22.5% from the December 15th total of 617,100 shares. Based on an average daily volume of 238,800 shares, the short-interest ratio is currently 3.2 days. Currently, 1.6% of the company's stock are short sold. View Teleflex's Current Options Chain.

Some companies that are related to Teleflex include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include Visa (V), Netflix (NFLX), NVIDIA (NVDA), Alibaba Group (BABA), ABIOMED (ABMD), Alphabet (GOOG), AbbVie (ABBV), DCP Midstream (DCP), JPMorgan Chase & Co. (JPM) and Lockheed Martin (LMT).

Teleflex's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Scout Investments Inc. (0.41%), Strs Ohio (0.33%), AMI Asset Management Corp (0.19%), Davis R M Inc. (0.19%), Mountain Pacific Investment Advisers Inc. ID (0.17%) and New York State Teachers Retirement System (0.15%). Company insiders that own Teleflex stock include Andrew A Krakauer, Benson Smith, Cameron P Hicks, George Babich Jr, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle, Thomas Anthony Kennedy and Thomas E Powell. View Institutional Ownership Trends for Teleflex.

TFX stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Janney Montgomery Scott LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Three Peaks Capital Management LLC, Braun Stacey Associates Inc., State of Alaska Department of Revenue, Tributary Capital Management LLC and Boenning & Scattergood Inc.. Company insiders that have sold Teleflex company stock in the last year include Benson Smith, Cameron P Hicks, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell. View Insider Buying and Selling for Teleflex.

TFX stock was purchased by a variety of institutional investors in the last quarter, including Scout Investments Inc., AMI Asset Management Corp, Strs Ohio, Columbus Circle Investors, New York State Teachers Retirement System, Gateway Investment Advisers LLC, First Hawaiian Bank and Davis R M Inc.. Company insiders that have bought Teleflex stock in the last two years include Andrew A Krakauer and John C Heinmiller. View Insider Buying and Selling for Teleflex.

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TFX stock can currently be purchased for approximately $380.02.

Teleflex has a market capitalization of $17.59 billion and generates $2.45 billion in revenue each year. The medical technology company earns $200.80 million in net income (profit) each year or $9.90 on an earnings per share basis. Teleflex employs 15,200 workers across the globe.View Additional Information About Teleflex.

The official website for Teleflex is http://www.teleflex.com/.

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]